By Jonathan Benson(NaturalNews) Amid all the controversy over genetically-modified (GM) crops and their pesticides and herbicides decimating bee populations all around the world, biotechnology behemoth Monsanto has decided to buy out one of the major international firms devoted to studying and protecting bees. According to a company announcement, Beeologics handed over the reins to Monsanto back on September 28, 2011, which means the gene-manipulating giant will now be able to control the flow of information and products coming from Beeologics for colony collapse disorder (CCD).Since 2007, Beeologics has been studying CCD, as well as Israeli Acute Paralysis Virus (IAPV), for the purpose of coming up with intervention-based ways to mitigate these conditions. And based on the way the company describes both CCD and IAPV on its website, Beeologics has largely taken the approach that intervention, rather than prevention, is the key to solving the global bee crisis.Now that Beeologics is owned and controlled by Monsanto, the company is sure to completely avoid dealing with the true causes of CCD and IAPV as they pertain to Monsanto's crop technologies -- GMOs and their chemical counterparts. So going into the future, it seems expected that Beeologics will come up with "scientific breakthroughs" that deny any link between CCD and GMO technologies, and instead blame mystery pathogens and other factors that require more chemicals to eliminate.According to Anthony Gucciardi at Activist Post, Beeologics has also long had a cozy relationship with the U.S. Department of Agriculture (USDA), which is convenient for Monsanto. The USDA, in fact, considers Beeologics to be one of the foremost bee research organizations in the world, as does the USDA's Agricultural Research Service (ARS), the mainstream media and "leading entomologists" worldwide, according to the company.